MBOT

Microbot Medical (MBOT)

Microbot Medical Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MBOT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/29	21 : 30	GlobeNewswire Inc.	Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™	NASDAQ:MBOT	Microbot Medical Inc
2024/04/15	21 : 30	GlobeNewswire Inc.	Microbot Medical Shares Status Following Recent Geopolitical Events	NASDAQ:MBOT	Microbot Medical Inc
2024/02/27	08 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MBOT	Microbot Medical Inc
2024/02/27	08 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MBOT	Microbot Medical Inc
2024/02/27	08 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MBOT	Microbot Medical Inc
2024/02/27	08 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:MBOT	Microbot Medical Inc
2024/02/21	06 : 35	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:MBOT	Microbot Medical Inc
2024/02/15	04 : 49	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:MBOT	Microbot Medical Inc
2024/02/05	21 : 30	GlobeNewswire Inc.	Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US	NASDAQ:MBOT	Microbot Medical Inc
2024/01/31	06 : 30	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MBOT	Microbot Medical Inc
2024/01/30	21 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBOT	Microbot Medical Inc
2024/01/30	21 : 20	GlobeNewswire Inc.	Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters	NASDAQ:MBOT	Microbot Medical Inc
2024/01/26	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MBOT	Microbot Medical Inc
2024/01/23	07 : 20	Edgar (US Regulatory)	Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]	NASDAQ:MBOT	Microbot Medical Inc
2024/01/18	21 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBOT	Microbot Medical Inc
2024/01/18	21 : 20	GlobeNewswire Inc.	Microbot Medical Expands US Clinical Infrastructure in Support of the Upcoming IDE Submission to Commence its First in Human Clinical Study	NASDAQ:MBOT	Microbot Medical Inc
2024/01/13	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBOT	Microbot Medical Inc
2024/01/13	06 : 16	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:MBOT	Microbot Medical Inc
2024/01/03	07 : 00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:MBOT	Microbot Medical Inc
2024/01/03	06 : 55	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBOT	Microbot Medical Inc
2023/12/29	22 : 00	GlobeNewswire Inc.	Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for $2.73 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules	NASDAQ:MBOT	Microbot Medical Inc
2023/12/28	21 : 30	GlobeNewswire Inc.	Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met	NASDAQ:MBOT	Microbot Medical Inc
2023/12/14	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBOT	Microbot Medical Inc
2023/12/14	22 : 15	GlobeNewswire Inc.	Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic	NASDAQ:MBOT	Microbot Medical Inc
2023/12/07	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:MBOT	Microbot Medical Inc
2023/12/07	22 : 00	GlobeNewswire Inc.	Microbot Medical Announces the Successful Completion of Its GLP Pivotal Pre-Clinical Study, a Critical Milestone for Its IDE submission to Commence Human Clinical Study	NASDAQ:MBOT	Microbot Medical Inc
2023/12/05	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:MBOT	Microbot Medical Inc
2023/12/02	07 : 15	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:MBOT	Microbot Medical Inc
2023/12/01	06 : 31	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:MBOT	Microbot Medical Inc
2023/11/21	23 : 12	GlobeNewswire Inc.	Microbot Medical Appoints Seasoned Medical Expert Dr. Juan Diaz- Cartelle as its New Chief Medical Officer in Anticipation of Its Clinical, Regulatory and Commercial Activities	NASDAQ:MBOT	Microbot Medical Inc